---
figid: PMC9639746__fimmu-13-996663-g001
pmcid: PMC9639746
image_filename: fimmu-13-996663-g001.jpg
figure_link: /pmc/articles/PMC9639746/figure/f1/
number: Figure 1
figure_title: ''
caption: The cGAS-STING pathway regulates each step of the cancer-immunity cycle.
  Combination therapy of STING agonists can target different steps of the cancer-immunity
  cycle and contribute to solving immunotherapy challenges in the corresponding immune
  types of tumors. APC, antigen-presenting cell; PD-L1, programmed death-ligand 1;
  DDR, DNA damage response; VEGF, vascular endothelial growth factor; IDO, indoleamine
  2,3-dioxygenase; ICIs, immune checkpoint inhibitors; CAR-T cell, chimeric antigen
  receptor-T cell. By Figdraw.
article_title: Cancer immunotherapy strategies that target the cGAS-STING pathway.
citation: Zhuoying Tian, et al. Front Immunol. 2022;13:996663.
year: '2022'

doi: 10.3389/fimmu.2022.996663
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.

keywords:
- cGAS
- STING
- cancer-immunity cycle
- immunotherapy
- tumor

---
